Standout Papers

Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Mono... 2013 2026 2017 2021 491
  1. Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma (2013)
    William W. Busse, Stephen T. Holgate et al. American Journal of Respiratory and Critical Care Medicine

Immediate Impact

4 by Nobel laureates 31 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

The basic immunology of asthma
2021 Standout
De novo design of protein logic gates
2020 StandoutScienceNobel
1 intermediate paper

Works of Joseph Lin being referenced

Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
2013 Standout
A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant
2006

Author Peers

Author Last Decade Papers Cites
Joseph Lin 907 190 1244 756 64 3.5k
Fabio Grassi 1849 250 2698 599 111 6.2k
Stanley van den Noort 914 124 1396 345 48 7.4k
Maria A. Bednarek 2249 192 1324 656 64 5.0k
Harald H.H. Göring 2136 391 814 569 147 5.8k
Frank A. Welsh 2442 235 549 907 99 6.2k
Menno van Lookeren Campagne 2608 266 1869 500 84 7.3k
David L. Nelson 630 208 862 373 99 3.4k
Bruno Stankoff 1353 85 401 346 126 5.6k
Floyd A. Davis 1034 155 1262 257 57 7.9k
Robert Weissert 1361 122 1701 355 118 5.5k

All Works

Loading papers...

Rankless by CCL
2026